Kymera Therapeutics, Inc. (KYMR) NASDAQ
$44.72 (0.05) (-0.11%)
Market Cap: $2.85B
As of 09/12/24 04:00 PM EDT. Market closed.
Kymera Therapeutics, Inc. (KYMR)
NASDAQ
$44.72
(0.05) (-0.11%)
Market Cap: $2.85B
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Nello Mainolfi M.D., Ph.D.
Full Time Employees
181
CEO Compensation (Base)
$640,000
CEO Compensation (Total)
$9.67M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Nello Mainolfi M.D., Ph.D.
Full Time Employees
181
CEO Compensation (Base)
$640,000
CEO Compensation (Total)
$9.67M
URL
Address
200 Arsenal Yards Boulevard, Suite 230, MA, Watertown, 02472.
PRICE CHART FOR KYMERA THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$44.70
Previous Close
$44.77
Days Range
$44.22 - $46.02
52 week range
$9.60 - $50.19
Volume
246,654
Avg. Volume (30 days)
577,450
Market Cap
$2.85B
Dividend Yield
-
P/E
(18.56)
Shares Outstanding
63,755,600
Open
$44.70
Previous Close
$44.77
Days Range
$44.22 - $46.02
52 week range
$9.60 - $50.19
Volume
246,654
Avg. Volume (30 days)
577,450
Market Cap
$2.85B
Dividend Yield
-
P/E
(18.56)
Shares Outstanding
63,755,600
FINANCIAL STATEMENTS FOR KYMERA THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR KYMERA THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Albers Jeffrey W. | Director | Aug 26, 2024 | Option Exercise | $10.34 | 5,000 | 51,700 | 5,000 | Aug 26, 2024, 06:31 PM |
| Albers Jeffrey W. | Director | Aug 26, 2024 | Sale | $49.10 | 5,000 | 245,508 | 0 | Aug 26, 2024, 06:31 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 20, 2024 | Buy | $46.41 | 1 | 46 | 5,516,986 | Aug 22, 2024, 04:03 PM |
| Gollob Jared | Chief Medical Officer | Jul 16, 2024 | Option Exercise | $2.08 | 23,145 | 48,142 | 118,885 | Jul 16, 2024, 06:00 PM |
| Gollob Jared | Chief Medical Officer | Jul 15, 2024 | Option Exercise | $2.08 | 16,455 | 34,226 | 112,195 | Jul 16, 2024, 06:00 PM |
| Gollob Jared | Chief Medical Officer | Jul 16, 2024 | Sale | $45.81 | 23,145 | 1,060,218 | 105,604 | Jul 16, 2024, 06:00 PM |
| Gollob Jared | Chief Medical Officer | Jul 15, 2024 | Sale | $45.15 | 16,455 | 742,925 | 95,740 | Jul 16, 2024, 06:00 PM |
| Booth Bruce | Director | Jul 09, 2024 | Sale | $38.21 | 453,960 | 17,346,919 | 4,523,951 | Jul 09, 2024, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 01, 2024 | Option Exercise | $5.33 | 18,773 | 100,060 | 649,959 | Jul 01, 2024, 04:30 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jun 27, 2024 | Option Exercise | $2.08 | 25,000 | 52,000 | 168,554 | Jun 28, 2024, 08:30 AM |
| Mainolfi Nello | Chief Executive Officer | Jun 18, 2024 | Option Exercise | $2.08 | 14,413 | 29,979 | 631,186 | Jun 20, 2024, 08:30 AM |
| Booth Bruce | Director | Jun 13, 2024 | Sale | $34.98 | 10,200 | 356,796 | 4,548,400 | Jun 14, 2024, 06:01 PM |
| Booth Bruce | Director | Jun 12, 2024 | Sale | $35.45 | 16,740 | 593,378 | 4,558,827 | Jun 14, 2024, 06:01 PM |
| Horobin Joanna | Director | Jun 07, 2024 | Option Exercise | $2.08 | 8,500 | 17,680 | 8,500 | Jun 07, 2024, 06:36 PM |
| Horobin Joanna | Director | Jun 07, 2024 | Sale | $32.99 | 8,500 | 280,400 | 6,313 | Jun 07, 2024, 06:36 PM |
| Chadwick Jeremy G | Chief Operating Officer | May 23, 2024 | Sale | $34.99 | 2,575 | 90,105 | 44,183 | May 23, 2024, 04:10 PM |
| Booth Bruce | Director | Mar 15, 2024 | Sale | $40.46 | 71,764 | 2,903,336 | 4,621,849 | Mar 15, 2024, 07:23 PM |
| Booth Bruce | Director | Mar 14, 2024 | Sale | $39.98 | 55,779 | 2,229,927 | 4,641,602 | Mar 15, 2024, 07:23 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 11, 2024 | Sale | $42.85 | 8,882 | 380,562 | 882,311 | Mar 13, 2024, 07:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 11, 2024 | Sale | $42.85 | 42,302 | 1,812,586 | 4,930,934 | Mar 13, 2024, 07:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 13, 2024 | Sale | $42.23 | 24,165 | 1,020,422 | 830,216 | Mar 13, 2024, 07:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 13, 2024 | Sale | $42.23 | 115,090 | 4,859,993 | 4,682,761 | Mar 13, 2024, 07:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 12, 2024 | Sale | $41.98 | 28,271 | 1,186,741 | 854,814 | Mar 13, 2024, 07:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Mar 12, 2024 | Sale | $41.98 | 134,647 | 5,652,072 | 4,799,746 | Mar 13, 2024, 07:53 PM |
| Booth Bruce | Director | Mar 13, 2024 | Sale | $42.23 | 139,255 | 5,880,415 | 4,682,761 | Mar 13, 2024, 07:52 PM |
| Booth Bruce | Director | Mar 12, 2024 | Sale | $41.98 | 162,918 | 6,838,813 | 4,799,746 | Mar 13, 2024, 07:52 PM |
| Booth Bruce | Director | Mar 11, 2024 | Sale | $42.85 | 51,184 | 2,193,148 | 4,930,934 | Mar 13, 2024, 07:52 PM |
| Gollob Jared | Chief Medical Officer | Mar 04, 2024 | Sale | $41.86 | 3,344 | 139,967 | 97,062 | Mar 04, 2024, 06:21 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 04, 2024 | Sale | $41.86 | 3,934 | 164,664 | 143,907 | Mar 04, 2024, 06:12 PM |
| Gollob Jared | Chief Medical Officer | Feb 27, 2024 | Option Exercise | $2.08 | 400 | 832 | 75,109 | Feb 29, 2024, 04:34 PM |
| Gollob Jared | Chief Medical Officer | Feb 27, 2024 | Sale | $45.00 | 400 | 18,000 | 74,709 | Feb 29, 2024, 04:34 PM |
| Albers Jeffrey W. | Director | Feb 20, 2024 | Option Exercise | $10.34 | 615 | 6,359 | 615 | Feb 21, 2024, 06:46 PM |
| Albers Jeffrey W. | Director | Feb 21, 2024 | Option Exercise | $10.34 | 4,385 | 45,341 | 4,385 | Feb 21, 2024, 06:46 PM |
| Albers Jeffrey W. | Director | Feb 21, 2024 | Sale | $39.05 | 4,385 | 171,227 | 0 | Feb 21, 2024, 06:46 PM |
| Albers Jeffrey W. | Director | Feb 20, 2024 | Sale | $39.07 | 615 | 24,031 | 0 | Feb 21, 2024, 06:46 PM |
| Gollob Jared | Chief Medical Officer | Feb 09, 2024 | Option Exercise | $2.08 | 46,137 | 95,965 | 120,846 | Feb 09, 2024, 07:47 PM |
| Gollob Jared | Chief Medical Officer | Feb 09, 2024 | Sale | $35.50 | 46,137 | 1,638,072 | 82,107 | Feb 09, 2024, 07:47 PM |
| Albers Jeffrey W. | Director | Jan 23, 2024 | Option Exercise | $10.34 | 10,000 | 103,400 | 10,000 | Jan 23, 2024, 07:37 PM |
| Albers Jeffrey W. | Director | Jan 23, 2024 | Sale | $30.05 | 10,000 | 300,470 | 0 | Jan 23, 2024, 07:37 PM |
| Chiniara Ellen | Chief Legal Officer | Jan 04, 2024 | Sale | $22.58 | 3,295 | 74,416 | 34,205 | Jan 05, 2024, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 02, 2024 | Option Exercise | $2.08 | 9,000 | 18,720 | 615,570 | Jan 02, 2024, 05:43 PM |
| BVF PARTNERS L P/IL | Director | Nov 03, 2023 | Buy | $14.07 | 197,699 | 2,781,407 | 2,656,191 | Nov 06, 2023, 06:07 PM |
| BVF PARTNERS L P/IL | Director | Nov 02, 2023 | Buy | $11.64 | 216,406 | 2,519,918 | 2,552,306 | Nov 06, 2023, 06:07 PM |
| Mainolfi Nello | Chief Executive Officer | Nov 03, 2023 | Option Exercise | $2.08 | 20,000 | 41,600 | 606,570 | Nov 06, 2023, 06:00 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 08, 2023 | Option Exercise | $2.08 | 12,000 | 24,960 | 586,570 | Aug 08, 2023, 04:30 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jun 02, 2023 | Option Exercise | $2.08 | 10,000 | 20,800 | 115,035 | Jun 02, 2023, 02:17 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 02, 2023 | Sale | $31.00 | 1,370 | 42,465 | 104,882 | Mar 03, 2023, 04:30 PM |
| BVF PARTNERS L P/IL | Director | Jan 12, 2023 | Buy | $31.24 | 18,897 | 590,391 | 2,494,688 | Jan 13, 2023, 05:08 PM |
| BVF PARTNERS L P/IL | Director | Jan 11, 2023 | Buy | $29.89 | 22,110 | 660,799 | 2,491,703 | Jan 13, 2023, 05:08 PM |
| Booth Bruce | Director | Jan 12, 2023 | Sale | $30.29 | 98,720 | 2,990,229 | 4,968,114 | Jan 13, 2023, 04:53 PM |
| Booth Bruce | Director | Jan 11, 2023 | Sale | $29.96 | 27,754 | 831,510 | 5,045,242 | Jan 13, 2023, 04:53 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Jan 11, 2023 | Sale | $29.96 | 21,683 | 649,623 | 5,045,242 | Jan 13, 2023, 04:50 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Jan 12, 2023 | Sale | $30.29 | 21,592 | 654,022 | 890,148 | Jan 13, 2023, 04:50 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Jan 12, 2023 | Sale | $30.29 | 77,128 | 2,336,207 | 4,968,114 | Jan 13, 2023, 04:50 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Jan 11, 2023 | Sale | $29.96 | 6,071 | 181,887 | 911,740 | Jan 13, 2023, 04:50 PM |
| Booth Bruce | Director | Dec 15, 2022 | Sale | $30.00 | 3,278 | 98,340 | 5,066,925 | Dec 16, 2022, 05:05 PM |
| Booth Bruce | Director | Dec 14, 2022 | Sale | $31.37 | 378,966 | 11,887,614 | 5,252,744 | Dec 16, 2022, 05:05 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Dec 15, 2022 | Sale | $30.00 | 717 | 21,510 | 917,811 | Dec 16, 2022, 05:03 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Dec 15, 2022 | Sale | $30.00 | 2,561 | 76,830 | 5,066,925 | Dec 16, 2022, 05:03 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Dec 14, 2022 | Sale | $31.37 | 82,889 | 2,600,108 | 969,833 | Dec 16, 2022, 05:03 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Dec 14, 2022 | Sale | $31.37 | 296,077 | 9,287,506 | 5,252,744 | Dec 16, 2022, 05:03 PM |
| Mainolfi Nello | Chief Executive Officer | Dec 08, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 573,700 | Dec 08, 2022, 06:11 PM |
| Booth Bruce | Director | Nov 03, 2022 | Sale | $30.00 | 96,397 | 2,891,910 | 5,365,563 | Nov 04, 2022, 04:31 PM |
| Booth Bruce | Director | Nov 02, 2022 | Sale | $30.02 | 123,619 | 3,711,042 | 5,440,875 | Nov 04, 2022, 04:31 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 02, 2022 | Sale | $30.02 | 96,581 | 2,899,362 | 5,440,875 | Nov 04, 2022, 04:30 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 03, 2022 | Sale | $30.00 | 21,085 | 632,550 | 1,001,417 | Nov 04, 2022, 04:30 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 03, 2022 | Sale | $30.00 | 75,312 | 2,259,360 | 5,365,563 | Nov 04, 2022, 04:30 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 02, 2022 | Sale | $30.02 | 27,038 | 811,681 | 1,022,502 | Nov 04, 2022, 04:30 PM |
| Booth Bruce | Director | Nov 01, 2022 | Sale | $30.60 | 77,030 | 2,357,240 | 5,541,183 | Nov 01, 2022, 07:36 PM |
| Booth Bruce | Director | Oct 31, 2022 | Sale | $30.23 | 120,622 | 3,646,403 | 5,597,638 | Nov 01, 2022, 07:36 PM |
| Booth Bruce | Director | Oct 28, 2022 | Sale | $30.00 | 91,050 | 2,731,500 | 5,691,877 | Nov 01, 2022, 07:36 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Oct 31, 2022 | Sale | $30.23 | 94,239 | 2,848,845 | 5,597,638 | Nov 01, 2022, 07:34 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Oct 28, 2022 | Sale | $30.00 | 19,915 | 597,450 | 1,092,771 | Nov 01, 2022, 07:34 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Oct 28, 2022 | Sale | $30.00 | 71,135 | 2,134,050 | 5,691,877 | Nov 01, 2022, 07:34 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 01, 2022 | Sale | $30.60 | 16,848 | 515,576 | 1,050,584 | Nov 01, 2022, 07:34 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Nov 01, 2022 | Sale | $30.60 | 60,182 | 1,841,664 | 5,541,183 | Nov 01, 2022, 07:34 PM |
| Atlas Venture Fund X, L.P. | 10% Owner | Oct 31, 2022 | Sale | $30.23 | 26,383 | 797,558 | 1,066,388 | Nov 01, 2022, 07:34 PM |
| Jacobs Bruce N. | Chief Financial Officer | Oct 21, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 81,279 | Oct 24, 2022, 08:00 AM |
| Jacobs Bruce N. | Chief Financial Officer | Oct 17, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 71,279 | Oct 17, 2022, 08:12 PM |
| Mainolfi Nello | Chief Executive Officer | Oct 17, 2022 | Option Exercise | $2.08 | 59,732 | 124,243 | 561,931 | Oct 17, 2022, 08:09 PM |
| BVF PARTNERS L P/IL | Director | Aug 22, 2022 | Buy | $26.00 | 545,525 | 14,183,650 | 2,480,742 | Aug 23, 2022, 05:35 PM |
| BVF PARTNERS L P/IL | Director | May 27, 2022 | Buy | $14.78 | 65,369 | 966,337 | 2,195,696 | May 31, 2022, 07:50 PM |
| BVF PARTNERS L P/IL | Director | May 26, 2022 | Buy | $14.21 | 224,057 | 3,183,984 | 2,159,903 | May 31, 2022, 07:50 PM |
| BVF PARTNERS L P/IL | Director | May 20, 2022 | Buy | $14.00 | 10,100 | 141,394 | 2,036,860 | May 24, 2022, 08:09 PM |
| BVF PARTNERS L P/IL | Director | May 06, 2022 | Buy | $19.25 | 100,000 | 1,925,500 | 2,030,977 | May 09, 2022, 07:20 PM |
| BVF PARTNERS L P/IL | Director | May 05, 2022 | Buy | $19.60 | 150,000 | 2,939,865 | 1,975,767 | May 09, 2022, 07:20 PM |
| Gollob Jared | Chief Medical Officer | May 04, 2022 | Option Exercise | $1.69 | 20,000 | 33,740 | 57,257 | May 04, 2022, 09:02 AM |
| Mainolfi Nello | Chief Executive Officer | May 03, 2022 | Option Exercise | $2.08 | 20,000 | 41,600 | 502,199 | May 03, 2022, 07:27 PM |
| Jacobs Bruce N. | Chief Financial Officer | May 03, 2022 | Option Exercise | $2.08 | 20,000 | 41,600 | 60,814 | May 03, 2022, 07:26 PM |
| BVF PARTNERS L P/IL | Director | Jan 31, 2022 | Buy | $40.70 | 34,408 | 1,400,406 | 1,900,272 | Jan 31, 2022, 07:44 PM |
| BVF PARTNERS L P/IL | Director | Jan 27, 2022 | Buy | $38.33 | 95,901 | 3,676,068 | 1,880,187 | Jan 31, 2022, 07:44 PM |
| BVF PARTNERS L P/IL | Director | Jan 24, 2022 | Buy | $37.76 | 272,767 | 10,300,637 | 1,822,145 | Jan 26, 2022, 07:43 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 14, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 482,199 | Jan 14, 2022, 05:30 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jan 14, 2022 | Option Exercise | $2.08 | 10,000 | 20,800 | 27,514 | Jan 14, 2022, 05:15 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jan 12, 2022 | Option Exercise | $2.08 | 15,000 | 31,200 | 32,514 | Jan 14, 2022, 05:01 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jan 12, 2022 | Sale | $51.85 | 15,000 | 777,684 | 26,087 | Jan 14, 2022, 05:01 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 11, 2022 | Option Exercise | $2.08 | 16,923 | 35,200 | 489,122 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 10, 2022 | Option Exercise | $2.08 | 22,465 | 46,727 | 494,664 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 12, 2022 | Option Exercise | $2.08 | 8,612 | 17,913 | 480,811 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 10, 2022 | Sale | $53.26 | 22,465 | 1,196,397 | 487,179 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 12, 2022 | Sale | $52.08 | 8,612 | 448,551 | 478,085 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jan 11, 2022 | Sale | $54.00 | 16,923 | 913,795 | 479,190 | Jan 12, 2022, 07:30 PM |
| Mainolfi Nello | Chief Executive Officer | Dec 16, 2021 | Option Exercise | $2.08 | 8,000 | 16,640 | 472,199 | Dec 16, 2021, 04:49 PM |
| Jacobs Bruce N. | Chief Financial Officer | Dec 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 27,514 | Dec 03, 2021, 06:43 PM |
| Jacobs Bruce N. | Chief Financial Officer | Dec 03, 2021 | Sale | $53.56 | 10,000 | 535,637 | 19,801 | Dec 03, 2021, 06:43 PM |
| Jacobs Bruce N. | Chief Financial Officer | Nov 23, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Nov 23, 2021, 04:59 PM |
| Gollob Jared | Chief Medical Officer | Nov 02, 2021 | Option Exercise | $2.08 | 14,996 | 31,192 | 39,653 | Nov 02, 2021, 06:45 PM |
| Gollob Jared | Chief Medical Officer | Nov 01, 2021 | Option Exercise | $1.45 | 24,607 | 35,783 | 67,154 | Nov 02, 2021, 06:45 PM |
| Gollob Jared | Chief Medical Officer | Nov 02, 2021 | Sale | $63.22 | 14,996 | 948,063 | 31,139 | Nov 02, 2021, 06:45 PM |
| Gollob Jared | Chief Medical Officer | Nov 01, 2021 | Sale | $61.78 | 42,497 | 2,625,595 | 59,767 | Nov 02, 2021, 06:45 PM |
| Mainolfi Nello | Chief Executive Officer | Oct 08, 2021 | Option Exercise | $2.08 | 41,544 | 86,412 | 505,743 | Oct 12, 2021, 04:30 PM |
| Mainolfi Nello | Chief Executive Officer | Oct 11, 2021 | Option Exercise | $2.08 | 6,456 | 13,428 | 470,655 | Oct 12, 2021, 04:30 PM |
| Mainolfi Nello | Chief Executive Officer | Oct 08, 2021 | Sale | $56.76 | 41,544 | 2,357,946 | 484,507 | Oct 12, 2021, 04:30 PM |
| Mainolfi Nello | Chief Executive Officer | Oct 11, 2021 | Sale | $53.68 | 6,456 | 346,590 | 464,943 | Oct 12, 2021, 04:30 PM |
| Jacobs Bruce N. | Chief Financial Officer | Sep 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Sep 03, 2021, 05:57 PM |
| Jacobs Bruce N. | Chief Financial Officer | Sep 03, 2021 | Sale | $60.12 | 10,000 | 601,180 | 8,756 | Sep 03, 2021, 05:57 PM |
| Chesworth Richard | Chief Scientific Officer | Aug 27, 2021 | Option Exercise | $20.00 | 33,779 | 675,580 | 33,779 | Aug 27, 2021, 04:55 PM |
| Chesworth Richard | Chief Scientific Officer | Aug 27, 2021 | Sale | $60.12 | 33,779 | 2,030,864 | 0 | Aug 27, 2021, 04:55 PM |
| Chesworth Richard | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $20.00 | 54,000 | 1,080,000 | 54,000 | Aug 19, 2021, 04:30 PM |
| Chesworth Richard | Chief Scientific Officer | Aug 17, 2021 | Sale | $50.37 | 54,000 | 2,720,182 | 45,191 | Aug 19, 2021, 04:30 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 19, 2021 | Option Exercise | $2.08 | 12,000 | 24,960 | 464,199 | Aug 19, 2021, 04:30 PM |
| Booth Bruce | Director | Aug 11, 2021 | Sale | $61.00 | 242,133 | 14,770,113 | 0 | Aug 12, 2021, 10:43 AM |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Aug 11, 2021 | Sale | $61.00 | 242,133 | 14,770,113 | 0 | Aug 12, 2021, 10:42 AM |
| Mainolfi Nello | Chief Executive Officer | Aug 03, 2021 | Option Exercise | $2.08 | 5,669 | 11,792 | 457,868 | Aug 05, 2021, 04:14 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 04, 2021 | Option Exercise | $2.08 | 1,037 | 2,157 | 453,236 | Aug 05, 2021, 04:14 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 04, 2021 | Sale | $60.03 | 1,037 | 62,253 | 452,199 | Aug 05, 2021, 04:14 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 03, 2021 | Sale | $60.07 | 5,669 | 340,533 | 452,199 | Aug 05, 2021, 04:14 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 29, 2021 | Option Exercise | $2.08 | 680 | 1,414 | 452,879 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 02, 2021 | Option Exercise | $2.08 | 23,456 | 48,788 | 475,655 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 30, 2021 | Option Exercise | $2.08 | 6,279 | 13,060 | 458,478 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Aug 02, 2021 | Sale | $60.30 | 23,456 | 1,414,404 | 454,023 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 30, 2021 | Sale | $60.07 | 6,279 | 377,167 | 452,199 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 29, 2021 | Sale | $60.00 | 680 | 40,800 | 452,199 | Aug 02, 2021, 05:53 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 28, 2021 | Option Exercise | $2.08 | 3,864 | 8,037 | 456,063 | Jul 28, 2021, 04:57 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 26, 2021 | Option Exercise | $2.08 | 9,015 | 18,751 | 461,214 | Jul 28, 2021, 04:57 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 28, 2021 | Sale | $60.15 | 3,864 | 232,410 | 452,199 | Jul 28, 2021, 04:57 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 26, 2021 | Sale | $60.15 | 9,015 | 542,237 | 452,199 | Jul 28, 2021, 04:57 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 08, 2021 | Option Exercise | $2.08 | 48,000 | 99,840 | 500,199 | Jul 09, 2021, 04:30 PM |
| Mainolfi Nello | Chief Executive Officer | Jul 08, 2021 | Sale | $49.70 | 48,000 | 2,385,628 | 482,969 | Jul 09, 2021, 04:30 PM |
| BVF PARTNERS L P/IL | Director | Jul 01, 2021 | Buy | $47.00 | 544,166 | 25,575,802 | 1,664,104 | Jul 06, 2021, 06:40 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jun 03, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 17,256 | Jun 04, 2021, 04:16 PM |
| Jacobs Bruce N. | Chief Financial Officer | Jun 03, 2021 | Sale | $46.87 | 10,000 | 468,695 | 11,494 | Jun 04, 2021, 04:16 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 23, 2021 | Option Exercise | $2.08 | 680 | 1,414 | 397,879 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 22, 2021 | Option Exercise | $2.08 | 10,959 | 22,795 | 408,158 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 26, 2021 | Option Exercise | $2.08 | 2,768 | 5,757 | 399,967 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 22, 2021 | Sale | $40.26 | 10,959 | 441,182 | 397,199 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 26, 2021 | Sale | $40.18 | 2,768 | 111,229 | 397,199 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 23, 2021 | Sale | $40.01 | 680 | 27,208 | 397,199 | Apr 26, 2021, 05:15 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 15, 2021 | Option Exercise | $2.08 | 4,940 | 10,275 | 396,139 | Apr 19, 2021, 07:12 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 19, 2021 | Option Exercise | $2.08 | 6,653 | 13,838 | 397,199 | Apr 19, 2021, 07:12 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 19, 2021 | Sale | $40.00 | 653 | 26,121 | 391,199 | Apr 19, 2021, 07:12 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 15, 2021 | Sale | $40.29 | 4,940 | 199,039 | 391,199 | Apr 19, 2021, 07:12 PM |
| Jacobs Bruce N. | Chief Financial Officer | Apr 13, 2021 | Option Exercise | $2.08 | 7,000 | 14,560 | 7,000 | Apr 13, 2021, 06:37 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 08, 2021 | Option Exercise | $2.08 | 9,939 | 20,673 | 386,138 | Apr 12, 2021, 06:11 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 12, 2021 | Option Exercise | $2.08 | 15,267 | 31,755 | 391,466 | Apr 12, 2021, 06:11 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 09, 2021 | Option Exercise | $2.08 | 22,794 | 47,412 | 398,993 | Apr 12, 2021, 06:11 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 12, 2021 | Sale | $32.62 | 15,267 | 497,981 | 381,104 | Apr 12, 2021, 06:11 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 09, 2021 | Sale | $33.68 | 22,794 | 767,750 | 379,941 | Apr 12, 2021, 06:11 PM |
| Mainolfi Nello | Chief Executive Officer | Apr 08, 2021 | Sale | $35.00 | 9,939 | 347,832 | 378,522 | Apr 12, 2021, 06:11 PM |
| Booth Bruce | Director | Mar 12, 2021 | Sale | $56.50 | 229,350 | 12,958,275 | 0 | Mar 16, 2021, 07:39 PM |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Mar 12, 2021 | Sale | $56.50 | 229,350 | 12,958,275 | 0 | Mar 16, 2021, 07:37 PM |
| Gollob Jared | Chief Medical Officer | Mar 11, 2021 | Option Exercise | $1.31 | 2,200 | 2,882 | 49,747 | Mar 15, 2021, 09:12 PM |
| Gollob Jared | Chief Medical Officer | Mar 15, 2021 | Option Exercise | $1.31 | 7,800 | 10,218 | 52,852 | Mar 15, 2021, 09:12 PM |
| Gollob Jared | Chief Medical Officer | Mar 15, 2021 | Sale | $60.17 | 10,305 | 620,052 | 42,547 | Mar 15, 2021, 09:12 PM |
| Gollob Jared | Chief Medical Officer | Mar 11, 2021 | Sale | $60.05 | 4,695 | 281,939 | 45,052 | Mar 15, 2021, 09:12 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 15, 2021 | Option Exercise | $2.08 | 8,195 | 17,046 | 8,195 | Mar 15, 2021, 09:08 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 11, 2021 | Option Exercise | $2.08 | 1,805 | 3,754 | 1,805 | Mar 15, 2021, 09:08 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 15, 2021 | Sale | $60.17 | 8,195 | 493,096 | 0 | Mar 15, 2021, 09:08 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 11, 2021 | Sale | $60.07 | 1,805 | 108,432 | 0 | Mar 15, 2021, 09:08 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 08, 2021 | Option Exercise | $2.08 | 10,000 | 20,800 | 10,000 | Mar 08, 2021, 08:01 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 08, 2021 | Sale | $50.65 | 10,000 | 506,470 | 2,301 | Mar 08, 2021, 08:01 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 03, 2021 | Option Exercise | $2.08 | 20,000 | 41,600 | 20,000 | Mar 05, 2021, 05:26 PM |
| Jacobs Bruce N. | Chief Financial Officer | Mar 03, 2021 | Sale | $44.78 | 20,000 | 895,634 | 13,119 | Mar 05, 2021, 05:26 PM |
| Gollob Jared | Chief Medical Officer | Feb 24, 2021 | Sale | $50.91 | 8,675 | 441,671 | 47,547 | Feb 24, 2021, 06:44 PM |
| Gollob Jared | Chief Medical Officer | Feb 23, 2021 | Sale | $49.65 | 19,285 | 957,554 | 56,222 | Feb 24, 2021, 06:44 PM |
| Gollob Jared | Chief Medical Officer | Feb 22, 2021 | Sale | $52.63 | 9,104 | 479,130 | 75,507 | Feb 24, 2021, 06:44 PM |
| Gollob Jared | Chief Medical Officer | Feb 18, 2021 | Sale | $55.94 | 6,499 | 363,540 | 93,498 | Feb 19, 2021, 07:27 PM |
| Gollob Jared | Chief Medical Officer | Feb 17, 2021 | Sale | $58.39 | 7,550 | 440,836 | 99,997 | Feb 19, 2021, 07:27 PM |
| Gollob Jared | Chief Medical Officer | Feb 19, 2021 | Sale | $55.09 | 8,887 | 489,559 | 84,611 | Feb 19, 2021, 07:27 PM |
| BVF PARTNERS L P/IL | Director | Aug 21, 2020 | Option Exercise | $20.00 | 978,693 | 19,573,860 | 1,359,109 | Aug 25, 2020, 06:48 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Albers Jeffrey W. | Director | 08/26/2024 | 51,700 |
| Albers Jeffrey W. | Director | 08/26/2024 | 245,508 |
| BAKER BROS. ADVISORS LP | Director | 08/20/2024 | 46 |
| Gollob Jared | Chief Medical Officer | 07/16/2024 | 48,142 |
| Gollob Jared | Chief Medical Officer | 07/15/2024 | 34,226 |
| Gollob Jared | Chief Medical Officer | 07/16/2024 | 1,060,218 |
| Gollob Jared | Chief Medical Officer | 07/15/2024 | 742,925 |
| Booth Bruce | Director | 07/09/2024 | 17,346,919 |
| Mainolfi Nello | Chief Executive Officer | 07/01/2024 | 100,060 |
| Jacobs Bruce N. | Chief Financial Officer | 06/27/2024 | 52,000 |
| Mainolfi Nello | Chief Executive Officer | 06/18/2024 | 29,979 |
| Booth Bruce | Director | 06/13/2024 | 356,796 |
| Booth Bruce | Director | 06/12/2024 | 593,378 |
| Horobin Joanna | Director | 06/07/2024 | 17,680 |
| Horobin Joanna | Director | 06/07/2024 | 280,400 |
| Chadwick Jeremy G | Chief Operating Officer | 05/23/2024 | 90,105 |
| Booth Bruce | Director | 03/15/2024 | 2,903,336 |
| Booth Bruce | Director | 03/14/2024 | 2,229,927 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/11/2024 | 380,562 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/11/2024 | 1,812,586 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/13/2024 | 1,020,422 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/13/2024 | 4,859,993 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/12/2024 | 1,186,741 |
| Atlas Venture Fund X, L.P. | 10% Owner | 03/12/2024 | 5,652,072 |
| Booth Bruce | Director | 03/13/2024 | 5,880,415 |
| Booth Bruce | Director | 03/12/2024 | 6,838,813 |
| Booth Bruce | Director | 03/11/2024 | 2,193,148 |
| Gollob Jared | Chief Medical Officer | 03/04/2024 | 139,967 |
| Jacobs Bruce N. | Chief Financial Officer | 03/04/2024 | 164,664 |
| Gollob Jared | Chief Medical Officer | 02/27/2024 | 832 |
| Gollob Jared | Chief Medical Officer | 02/27/2024 | 18,000 |
| Albers Jeffrey W. | Director | 02/20/2024 | 6,359 |
| Albers Jeffrey W. | Director | 02/21/2024 | 45,341 |
| Albers Jeffrey W. | Director | 02/21/2024 | 171,227 |
| Albers Jeffrey W. | Director | 02/20/2024 | 24,031 |
| Gollob Jared | Chief Medical Officer | 02/09/2024 | 95,965 |
| Gollob Jared | Chief Medical Officer | 02/09/2024 | 1,638,072 |
| Albers Jeffrey W. | Director | 01/23/2024 | 103,400 |
| Albers Jeffrey W. | Director | 01/23/2024 | 300,470 |
| Chiniara Ellen | Chief Legal Officer | 01/04/2024 | 74,416 |
| Mainolfi Nello | Chief Executive Officer | 01/02/2024 | 18,720 |
| BVF PARTNERS L P/IL | Director | 11/03/2023 | 2,781,407 |
| BVF PARTNERS L P/IL | Director | 11/02/2023 | 2,519,918 |
| Mainolfi Nello | Chief Executive Officer | 11/03/2023 | 41,600 |
| Mainolfi Nello | Chief Executive Officer | 08/08/2023 | 24,960 |
| Jacobs Bruce N. | Chief Financial Officer | 06/02/2023 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 03/02/2023 | 42,465 |
| BVF PARTNERS L P/IL | Director | 01/12/2023 | 590,391 |
| BVF PARTNERS L P/IL | Director | 01/11/2023 | 660,799 |
| Booth Bruce | Director | 01/12/2023 | 2,990,229 |
| Booth Bruce | Director | 01/11/2023 | 831,510 |
| Atlas Venture Fund X, L.P. | 10% Owner | 01/11/2023 | 649,623 |
| Atlas Venture Fund X, L.P. | 10% Owner | 01/12/2023 | 654,022 |
| Atlas Venture Fund X, L.P. | 10% Owner | 01/12/2023 | 2,336,207 |
| Atlas Venture Fund X, L.P. | 10% Owner | 01/11/2023 | 181,887 |
| Booth Bruce | Director | 12/15/2022 | 98,340 |
| Booth Bruce | Director | 12/14/2022 | 11,887,614 |
| Atlas Venture Fund X, L.P. | 10% Owner | 12/15/2022 | 21,510 |
| Atlas Venture Fund X, L.P. | 10% Owner | 12/15/2022 | 76,830 |
| Atlas Venture Fund X, L.P. | 10% Owner | 12/14/2022 | 2,600,108 |
| Atlas Venture Fund X, L.P. | 10% Owner | 12/14/2022 | 9,287,506 |
| Mainolfi Nello | Chief Executive Officer | 12/08/2022 | 20,800 |
| Booth Bruce | Director | 11/03/2022 | 2,891,910 |
| Booth Bruce | Director | 11/02/2022 | 3,711,042 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/02/2022 | 2,899,362 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/03/2022 | 632,550 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/03/2022 | 2,259,360 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/02/2022 | 811,681 |
| Booth Bruce | Director | 11/01/2022 | 2,357,240 |
| Booth Bruce | Director | 10/31/2022 | 3,646,403 |
| Booth Bruce | Director | 10/28/2022 | 2,731,500 |
| Atlas Venture Fund X, L.P. | 10% Owner | 10/31/2022 | 2,848,845 |
| Atlas Venture Fund X, L.P. | 10% Owner | 10/28/2022 | 597,450 |
| Atlas Venture Fund X, L.P. | 10% Owner | 10/28/2022 | 2,134,050 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/01/2022 | 515,576 |
| Atlas Venture Fund X, L.P. | 10% Owner | 11/01/2022 | 1,841,664 |
| Atlas Venture Fund X, L.P. | 10% Owner | 10/31/2022 | 797,558 |
| Jacobs Bruce N. | Chief Financial Officer | 10/21/2022 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 10/17/2022 | 20,800 |
| Mainolfi Nello | Chief Executive Officer | 10/17/2022 | 124,243 |
| BVF PARTNERS L P/IL | Director | 08/22/2022 | 14,183,650 |
| BVF PARTNERS L P/IL | Director | 05/27/2022 | 966,337 |
| BVF PARTNERS L P/IL | Director | 05/26/2022 | 3,183,984 |
| BVF PARTNERS L P/IL | Director | 05/20/2022 | 141,394 |
| BVF PARTNERS L P/IL | Director | 05/06/2022 | 1,925,500 |
| BVF PARTNERS L P/IL | Director | 05/05/2022 | 2,939,865 |
| Gollob Jared | Chief Medical Officer | 05/04/2022 | 33,740 |
| Mainolfi Nello | Chief Executive Officer | 05/03/2022 | 41,600 |
| Jacobs Bruce N. | Chief Financial Officer | 05/03/2022 | 41,600 |
| BVF PARTNERS L P/IL | Director | 01/31/2022 | 1,400,406 |
| BVF PARTNERS L P/IL | Director | 01/27/2022 | 3,676,068 |
| BVF PARTNERS L P/IL | Director | 01/24/2022 | 10,300,637 |
| Mainolfi Nello | Chief Executive Officer | 01/14/2022 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 01/14/2022 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 01/12/2022 | 31,200 |
| Jacobs Bruce N. | Chief Financial Officer | 01/12/2022 | 777,684 |
| Mainolfi Nello | Chief Executive Officer | 01/11/2022 | 35,200 |
| Mainolfi Nello | Chief Executive Officer | 01/10/2022 | 46,727 |
| Mainolfi Nello | Chief Executive Officer | 01/12/2022 | 17,913 |
| Mainolfi Nello | Chief Executive Officer | 01/10/2022 | 1,196,397 |
| Mainolfi Nello | Chief Executive Officer | 01/12/2022 | 448,551 |
| Mainolfi Nello | Chief Executive Officer | 01/11/2022 | 913,795 |
| Mainolfi Nello | Chief Executive Officer | 12/16/2021 | 16,640 |
| Jacobs Bruce N. | Chief Financial Officer | 12/03/2021 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 12/03/2021 | 535,637 |
| Jacobs Bruce N. | Chief Financial Officer | 11/23/2021 | 20,800 |
| Gollob Jared | Chief Medical Officer | 11/02/2021 | 31,192 |
| Gollob Jared | Chief Medical Officer | 11/01/2021 | 35,783 |
| Gollob Jared | Chief Medical Officer | 11/02/2021 | 948,063 |
| Gollob Jared | Chief Medical Officer | 11/01/2021 | 2,625,595 |
| Mainolfi Nello | Chief Executive Officer | 10/08/2021 | 86,412 |
| Mainolfi Nello | Chief Executive Officer | 10/11/2021 | 13,428 |
| Mainolfi Nello | Chief Executive Officer | 10/08/2021 | 2,357,946 |
| Mainolfi Nello | Chief Executive Officer | 10/11/2021 | 346,590 |
| Jacobs Bruce N. | Chief Financial Officer | 09/03/2021 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 09/03/2021 | 601,180 |
| Chesworth Richard | Chief Scientific Officer | 08/27/2021 | 675,580 |
| Chesworth Richard | Chief Scientific Officer | 08/27/2021 | 2,030,864 |
| Chesworth Richard | Chief Scientific Officer | 08/17/2021 | 1,080,000 |
| Chesworth Richard | Chief Scientific Officer | 08/17/2021 | 2,720,182 |
| Mainolfi Nello | Chief Executive Officer | 08/19/2021 | 24,960 |
| Booth Bruce | Director | 08/11/2021 | 14,770,113 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 08/11/2021 | 14,770,113 |
| Mainolfi Nello | Chief Executive Officer | 08/03/2021 | 11,792 |
| Mainolfi Nello | Chief Executive Officer | 08/04/2021 | 2,157 |
| Mainolfi Nello | Chief Executive Officer | 08/04/2021 | 62,253 |
| Mainolfi Nello | Chief Executive Officer | 08/03/2021 | 340,533 |
| Mainolfi Nello | Chief Executive Officer | 07/29/2021 | 1,414 |
| Mainolfi Nello | Chief Executive Officer | 08/02/2021 | 48,788 |
| Mainolfi Nello | Chief Executive Officer | 07/30/2021 | 13,060 |
| Mainolfi Nello | Chief Executive Officer | 08/02/2021 | 1,414,404 |
| Mainolfi Nello | Chief Executive Officer | 07/30/2021 | 377,167 |
| Mainolfi Nello | Chief Executive Officer | 07/29/2021 | 40,800 |
| Mainolfi Nello | Chief Executive Officer | 07/28/2021 | 8,037 |
| Mainolfi Nello | Chief Executive Officer | 07/26/2021 | 18,751 |
| Mainolfi Nello | Chief Executive Officer | 07/28/2021 | 232,410 |
| Mainolfi Nello | Chief Executive Officer | 07/26/2021 | 542,237 |
| Mainolfi Nello | Chief Executive Officer | 07/08/2021 | 99,840 |
| Mainolfi Nello | Chief Executive Officer | 07/08/2021 | 2,385,628 |
| BVF PARTNERS L P/IL | Director | 07/01/2021 | 25,575,802 |
| Jacobs Bruce N. | Chief Financial Officer | 06/03/2021 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 06/03/2021 | 468,695 |
| Mainolfi Nello | Chief Executive Officer | 04/23/2021 | 1,414 |
| Mainolfi Nello | Chief Executive Officer | 04/22/2021 | 22,795 |
| Mainolfi Nello | Chief Executive Officer | 04/26/2021 | 5,757 |
| Mainolfi Nello | Chief Executive Officer | 04/22/2021 | 441,182 |
| Mainolfi Nello | Chief Executive Officer | 04/26/2021 | 111,229 |
| Mainolfi Nello | Chief Executive Officer | 04/23/2021 | 27,208 |
| Mainolfi Nello | Chief Executive Officer | 04/15/2021 | 10,275 |
| Mainolfi Nello | Chief Executive Officer | 04/19/2021 | 13,838 |
| Mainolfi Nello | Chief Executive Officer | 04/19/2021 | 26,121 |
| Mainolfi Nello | Chief Executive Officer | 04/15/2021 | 199,039 |
| Jacobs Bruce N. | Chief Financial Officer | 04/13/2021 | 14,560 |
| Mainolfi Nello | Chief Executive Officer | 04/08/2021 | 20,673 |
| Mainolfi Nello | Chief Executive Officer | 04/12/2021 | 31,755 |
| Mainolfi Nello | Chief Executive Officer | 04/09/2021 | 47,412 |
| Mainolfi Nello | Chief Executive Officer | 04/12/2021 | 497,981 |
| Mainolfi Nello | Chief Executive Officer | 04/09/2021 | 767,750 |
| Mainolfi Nello | Chief Executive Officer | 04/08/2021 | 347,832 |
| Booth Bruce | Director | 03/12/2021 | 12,958,275 |
| ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 03/12/2021 | 12,958,275 |
| Gollob Jared | Chief Medical Officer | 03/11/2021 | 2,882 |
| Gollob Jared | Chief Medical Officer | 03/15/2021 | 10,218 |
| Gollob Jared | Chief Medical Officer | 03/15/2021 | 620,052 |
| Gollob Jared | Chief Medical Officer | 03/11/2021 | 281,939 |
| Jacobs Bruce N. | Chief Financial Officer | 03/15/2021 | 17,046 |
| Jacobs Bruce N. | Chief Financial Officer | 03/11/2021 | 3,754 |
| Jacobs Bruce N. | Chief Financial Officer | 03/15/2021 | 493,096 |
| Jacobs Bruce N. | Chief Financial Officer | 03/11/2021 | 108,432 |
| Jacobs Bruce N. | Chief Financial Officer | 03/08/2021 | 20,800 |
| Jacobs Bruce N. | Chief Financial Officer | 03/08/2021 | 506,470 |
| Jacobs Bruce N. | Chief Financial Officer | 03/03/2021 | 41,600 |
| Jacobs Bruce N. | Chief Financial Officer | 03/03/2021 | 895,634 |
| Gollob Jared | Chief Medical Officer | 02/24/2021 | 441,671 |
| Gollob Jared | Chief Medical Officer | 02/23/2021 | 957,554 |
| Gollob Jared | Chief Medical Officer | 02/22/2021 | 479,130 |
| Gollob Jared | Chief Medical Officer | 02/18/2021 | 363,540 |
| Gollob Jared | Chief Medical Officer | 02/17/2021 | 440,836 |
| Gollob Jared | Chief Medical Officer | 02/19/2021 | 489,559 |
| BVF PARTNERS L P/IL | Director | 08/21/2020 | 19,573,860 |
Load More Insider Transactions
FUNDS WITH A POSITION IN KYMERA THERAPEUTICS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 6,001,262 | 3.73% | 0.09% | Other |
| BLACKROCK INC. | 4,155,429 | 0.00281% | 13.67% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,054,220 | 0.00276% | 9.17% | Other |
| CANDRIAM S.C.A. | 238,165 | 0.04% | -27.46% | Other |
| D. E. SHAW & CO., INC. | 295,572 | 0.00825% | 336.19% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 223,413 | 0.06% | New | Growth |
| RENAISSANCE TECHNOLOGIES LLC | 143,093 | 0.00724% | New | Other |
| TUDOR INVESTMENT CORP ET AL | 46,373 | 0.01% | Exited | Event Driven, Other |
| ROYCE & ASSOCIATES LP | 7,076 | 0.00254% | Exited | Value |
CHANGE IN SHARES OUTSTANDING FOR KYMERA THERAPEUTICS, INC.
STOCK BUYBACKS FOR KYMERA THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
21.14%
2Q
06/30/2023
21.33%
3Q
03/31/2023
21.63%
4Q
12/31/2022
22.16%
5Q
09/30/2022
29.77%
6Q
06/30/2022
36.69%
7Q
03/31/2022
37.02%
8Q
12/31/2021
37.60%
9Q
09/30/2021
39.55%
10Q
06/30/2021
56.94%
11Q
03/31/2021
58.50%
12Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KYMERA THERAPEUTICS, INC.
LOADING...